Category Archives: Myocardial Infarction

Local medical experts have an innovative theory on the connection between the most common endocrine disease in women of reproductive age and their increased risk of cardiovascular disease, which they tested through animal experiments. The research was published by world-leading journal Circulation, offering important evidence for new intervention measures on cardiovascular disease in young women, boosting the development of innovative medications and therapies Continue reading →

Abstract Objective To assess the absolute treatment effects of intravascular imaging guided versus angiography guided percutaneous coronary intervention in patients with coronary artery disease, considering their baseline risk. Design Systematic review and meta-analysis. Data sources PubMed/Medline, Embase, and Cochrane Library databases up to 31 August 2023. Continue reading →

The BMA and the Royal College of Nursing (RCN) have asked the government to designate long term conditions caused by covid-19 as occupational diseases. This would mean that staff with these conditions could receive financial assistance in recognition that they had, most probably, caught the initial infection at work Continue reading →

Data presentations at AHA 2023 Meeting reinforce treatment with XARELTOplus aspirin consistently reduces major cardiovascular events (MACE) as well as major adverse limb events (MALE) in complex patients with PAD Janssen continues commitment to supporting PAD patients with ongoing research to help understand this undertreated and underdiagnosed disease1 TITUSVILLE, N.J., Nov. 14, 2023 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefit of XARELTO (rivaroxaban [2.5 mg twice daily plus aspirin 100 mg once daily]) over standard of care (aspirin alone) Continue reading →

The time to clinical benefit with Inpefa (sotagliflozin) was about three months, which was identified through a post hoc analysis of the SCORED clinical trial. This analysis was presented at the American Heart Association Scientific Sessions meeting in Philadelphia by Rahul Aggarwal, M.D., a cardiology fellow at Brigham and Womens Hospital in Boston Continue reading →

Wu S, Wu B, Liu M, Chen Z, Wang W, Anderson CS, Sandercock P, Wang Y, Huang Y, Cui L, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol Continue reading →

Philadelphia - Stress can play a critical role in heart disease in women, and researchers say its an area that demands more study and attention. Several researchers discussed the role that stress plays in cardiovascular disease among women during a session at the American Heart Association Scientific Sessions in Philadelphia Saturday. (Photo: Ron Southwick) The role of stress in cardiovascular disease among women was the subject of a session at the American Heart Association Scientific Sessions in Philadelphia. Continue reading →

Hu X, De Silva TM, Chen J, Faraci FM. Cerebral vascular Disease and Neurovascular Injury in ischemic Stroke Continue reading →

MONDAY, Nov. 13, 2023 (HealthDay News) -- Daily marijuana use is associated with incident heart failure, and cannabis use disorder (CUD) is associated with increased odds of major adverse cardiac and cerebrovascular events (MACCE), according to two studies presented at the American Heart Association Scientific Sessions 2023, held from Nov Continue reading →

Introduction Cardiac conduction block (CCB) is characterised by a disease manifested as the delay or interruption in the transmission of an impulse within the conduction system, including the sinoatrial, atrioventricular block (AVB), and bundle branch block (BBB).1 Regardless of the type of conduction block, disease progression in severe cases significantly increases the risk of cardiovascular morbidity and mortality.24 Although pacemaker implantation is an effective treatment for end-stage conduction block diseases, it carries the risk of infection and thrombosis and is associated with long-term adverse cardiac remodelling.57 Therefore, it is particularly important to identify high-risk individuals with conduction block and implement early measures to avoid illness onset. Continue reading →